Changchun Genescience Pharmaceutical Co., Ltd.
Clinical trials sponsored by Changchun Genescience Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bacterial vaginosis drug passes first safety check in healthy volunteers Results expected Sep 2026 (estimated)
- New pill could tame phenylketonuria by blocking amino acid absorption Results expected Sep 2026 (estimated)
- New injection for Graves' disease enters first human tests Results expected Oct 2026 (estimated)
- Head-to-Head: which drug tames high prolactin better? Results expected Nov 2026 (estimated)
- New growth hormone drug enters first human tests Results expected Nov 2026 (estimated)
-
New shot could help control breast cancer in younger women
Disease control OngoingThis study tests a new injectable form of leuprolide in 211 premenopausal women with hormone-positive breast cancer. The goal is to see if it can safely keep estrogen at postmenopausal levels for nearly a year, which helps control cancer growth. Participants receive the drug and …
Phase 3 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New Drug's journey through the body tracked in small study
Knowledge-focused OngoingThis early-stage study looks at how healthy postmenopausal women absorb, break down, and eliminate the experimental drug GS1-144. Six participants will take a single oral dose, and researchers will measure the drug and its byproducts in blood, urine, and stool. The goal is purely…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Healthy volunteers needed to compare generic vs. brand cabergoline
Knowledge-focused OngoingThis study checks if a new version of cabergoline tablets works the same as the standard version in 72 healthy Chinese adults aged 18-45. Participants take one dose of each version under fasting or after a meal, with blood tests to measure drug levels. The goal is to confirm bioe…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC